ID   CAL-1 [Human plasmacytoid dendritic]
AC   CVCL_5G46
SY   Cal-1
DR   DSMZ; ACC-923
DR   DSMZCellDive; ACC-923
DR   Lonza; 1599
DR   Wikidata; Q54808383
RX   Patent=JP5011520;
RX   PubMed=15765784;
WW   https://web.archive.org/web/20160706131224/http://www.clg.niigata-u.ac.jp:80/~matak/eng/resmat12.pdf
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-20595.
CC   Population: Japanese.
CC   Doubling time: ~25-35 hours (DSMZ=ACC-923).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasmacytoid dendritic cell; CL=CL_0000784.
ST   Source(s): DSMZ
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,10
ST   D16S539: 8,9
ST   D18S51: 13,23
ST   D19S433: 14
ST   D21S11: 30,31
ST   D2S1338: 19,23
ST   D3S1358: 17
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 15,18
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C7203; Blastic plasmacytoid dendritic cell neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 05-10-23; Version: 12
//
RX   Patent=JP5011520;
RA   Kamihira K., Maeda T.;
RT   "A novel human plasmacytoid dendritic cell line.";
RL   Patent number JP5011520, 29-Aug-2012.
//
RX   PubMed=15765784; DOI=10.1532/IJH97.04116;
RA   Maeda T., Murata K., Fukushima T., Sugahara K., Tsuruda K., Anami M.,
RA   Onimaru Y., Tsukasaki K., Tomonaga M., Moriuchi R., Hasegawa H.,
RA   Yamada Y., Kamihira S.;
RT   "A novel plasmacytoid dendritic cell line, CAL-1, established from a
RT   patient with blastic natural killer cell lymphoma.";
RL   Int. J. Hematol. 81:148-154(2005).
//